1-3 of 3
breast carcinoma, lobular, invasive
Close
Sort by
Journal Articles

CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML

Bérengère Salomé, Alejandra Gomez-Cadena, Romain Loyon, Madeleine Suffiotti, Valentina Salvestrini, Tania Wyss, Giulia Vanoni, Dan Fu Ruan, Marianna Rossi, Alessandra Tozzo, Paolo Tentorio, Elena Bruni, Carsten Riether, Eva-Maria Jacobsen, Peter Jandus, Curdin Conrad, Manfred Hoenig, Ansgar Schulz, Katarzyna Michaud, Matteo Giovanni Della Porta, Silvia Salvatore, Ping-Chih Ho, David Gfeller, Adrian Ochsenbein, Domenico Mavilio, Antonio Curti, Emanuela Marcenaro, Alexander Steinle, Amir Horowitz, Pedro Romero, Sara Trabanelli, Camilla Jandus
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3674–3687.
https://doi.org/10.1182/bloodadvances.2018030478
Published: 2019
Includes: Supplemental data
Journal Articles

Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease

Mette D. Hazenberg, Nienke J. E. Haverkate, Yannouck F. van Lier, Hergen Spits, Lisette Krabbendam, Willem A. Bemelman, Christianne J. Buskens, Bianca Blom, Medya M. Shikhagaie
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3650–3660.
https://doi.org/10.1182/bloodadvances.2019000176
Published: 2019
Includes: Supplemental data
Journal Articles

A functional DC cross talk promotes human ILC homeostasis in humanized mice

Silvia Lopez-Lastra, Guillemette Masse-Ranson, Oriane Fiquet, Sylvie Darche, Nicolas Serafini, Yan Li, Mathilde Dusséaux, Helene Strick-Marchand, James P. Di Santo
Journal: Blood Advances
Blood Adv (2017) 1 (10): 601–614.
https://doi.org/10.1182/bloodadvances.2017004358
Published: 2017
Includes: Supplemental data